Prolonged-Release Fampridine Induces Sustained Clinically Meaningful Improvements in Walking Ability in People with Multiple Sclerosis: Results from the ENHANCE Trial

J Hobart; T Ziemssen; P Feys; M Linnebank; A Goodman; R Farrell; V Englishby; M McNeill; I Chang; L Mehta; J Elkins

Prolonged-Release Fampridine Induces Sustained Clinically Meaningful Improvements in Walking Ability in People with Multiple Sclerosis: Results from the ENHANCE Trial

J Hobart
, T Ziemssen
, P Feys
, M Linnebank
, A Goodman
, R Farrell
, V Englishby
, M McNeill
, I Chang
, L Mehta
, J Elkins

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
Publication status	Published - 18 Apr 2017

Cite this

@conference{cd0189b6f5694fe0b34a1f63382098ea,

title = "Prolonged-Release Fampridine Induces Sustained Clinically Meaningful Improvements in Walking Ability in People with Multiple Sclerosis: Results from the ENHANCE Trial",

author = "J Hobart and T Ziemssen and P Feys and M Linnebank and A Goodman and R Farrell and V Englishby and M McNeill and I Chang and L Mehta and J Elkins",

year = "2017",

month = apr,

day = "18",

language = "English",

}

TY - CONF

T1 - Prolonged-Release Fampridine Induces Sustained Clinically Meaningful Improvements in Walking Ability in People with Multiple Sclerosis: Results from the ENHANCE Trial

AU - Hobart, J

AU - Ziemssen, T

AU - Feys, P

AU - Linnebank, M

AU - Goodman, A

AU - Farrell, R

AU - Englishby, V

AU - McNeill, M

AU - Chang, I

AU - Mehta, L

AU - Elkins, J

PY - 2017/4/18

Y1 - 2017/4/18

UR - https://n.neurology.org/content/88/16_Supplement/P6.364

M3 - Conference paper (not formally published)

ER -

Prolonged-Release Fampridine Induces Sustained Clinically Meaningful Improvements in Walking Ability in People with Multiple Sclerosis: Results from the ENHANCE Trial

Other files and links

Cite this